K052716 is an FDA 510(k) clearance for the RAPIRUN H. PYLORI ANTIBODY DETECTION KIT. Classified as Helicobacter Pylori (product code LYR), Class I - General Controls.
Submitted by Otsuka Pharmaceutical Co., Ltd. (North Attleboro, US). The FDA issued a Cleared decision on November 16, 2006 after a review of 413 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3110 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Microbiology submissions.
View all Otsuka Pharmaceutical Co., Ltd. devices